Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018

SELL
$29.98 - $46.35 $5,996 - $9,270
-200 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$31.85 - $46.95 $3,185 - $4,695
-100 Reduced 33.33%
200 $9,000
Q3 2017

Nov 15, 2017

SELL
$35.7 - $39.5 $3,570 - $3,950
-100 Reduced 25.0%
300 $11,000
Q2 2017

Aug 15, 2017

BUY
N/A
400
400 $19,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $804M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.